Construction method and application of rodent model of novel coronavirus infection
An animal model, coronavirus technology, applied in animal husbandry, etc., can solve the problem that the new coronavirus model cannot normally express the human ACE2 receptor protein lung physiological state, and achieve easy operation, low construction cost, and high infection efficiency Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0049] This embodiment provides a method for constructing a rodent model of novel coronavirus SARS-CoV-2 infection using a bleomycin injury model and Tdtomato fluorescent protein-labeled human bronchial basal cells, comprising the following steps:
[0050] (1) Labeling of human bronchial basal cells: Mix lentiviral packaging plasmids pHIV-dTomato, psPAX2 and pMD2.G at a mass ratio of 5:3.75:1.25, transfect packaging cells 293T, and co-culture for 72 hours , collect the culture supernatant containing Tdtomato lentivirus, and centrifuge at 2000g for 10 minutes at 4°C to remove cell debris. The supernatant was filtered through a 0.45 μm filter and collected in an ultracentrifuge tube. Concentrate by ultracentrifugation at 25,000 g at 4°C to obtain a Tdtomato lentivirus suspension. After determining the titer of Tdtomato lentivirus, according to every 1×10 6 Individual bronchial basal cells added 10 7 The Tdtomato lentivirus of TU was co-cultured, and the medium was changed aft...
Embodiment 2
[0064] The present embodiment provides a kind of method adopting bleomycin injury model and human bronchial basal layer cell to construct the rodent model infected by novel coronavirus SARS-CoV-2, comprising the following steps:
[0065] (1) Construction of lung injury model: prepare 6-8 weeks old NOD.CB17-Prkdc scid / NcrCrl mice were divided into no-transplant control group, 4-day post-infection group and 21-day post-infection group, with one mouse in each group. After inhalational anesthesia with isoflurane, the trachea was intubated, and the bleomycin-PBS solution was administered to the lungs of the three groups of mice through the catheter through a syringe, with a volume of 50 μL for each mouse. The dose is 50 μg bleomycin / monkey.
[0066] (2) Cell transplantation: 7 days after administration of bleomycin, the mice in the 4-day post-infection group and the 21-day post-infection group were anesthetized with isoflurane again and then intubated. Take the human bronchial b...
Embodiment 3
[0070] This embodiment provides a method for constructing a rodent model of novel coronavirus SARS-CoV-2 infection using lipopolysaccharide combined with porcine trypsin-induced lung injury model and human bronchial basal layer cells, comprising the following steps:
[0071] (1) Construction of lung injury model: prepare three 6-8 week old NOD.CB17-Prkdc scid / NcrCrl mice. After anesthesia with isoflurane, each mouse was given a premixed solution of 40 μL porcine trypsin (10 U / mL) and 0.8 μL lipopolysaccharide (10 mg / mL) through the glottis into the trachea (the solvent was sterile PBS) . All mice were injured by continuous instillation for 3 days, once a day, and the volume of each instillation premix was 40.8 μL, and the lung injury model was established.
[0072] (2) Cell transplantation: Cell transplantation was carried out on the second day after the establishment of the lung injury model. After anesthesia with isoflurane, the human bronchial basal layer cell suspension...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com